Earnings Feed
Start Free
OxySure Therapeutics, Inc.·5

Feb 16, 5:39 PM ET

OxySure Therapeutics, Inc. 5

5 · OxySure Therapeutics, Inc. · Filed Feb 16, 2016

Insider Transaction Report

Form 5
Period: 2015-12-31
OxySure Therapeutics, Inc.OXYS
Ross Julian T
DirectorCEO, President, and Secretary10% Owner
Transactions
  • Award

    Options (right to buy)

    2015-12-31$0.20/sh+1,000,000$200,000→ 2,417,488 total
    Exercise: $0.20From: 2016-01-01Exp: 2021-01-01→ Common stock (1,000,000 underlying)
  • Award

    Common stock

    2015-12-31$0.20/sh+500,000$100,000→ 672,324 total
Holdings

  • Common stock

    172,324

  • Options (right to buy)

    Exercise: $0.25From: 2014-04-05Exp: 2019-12-05→ Common stock (1,417,488 underlying)
    1,417,488

  • Common stock

    (indirect: By Trust)
    400,000

  • Common stock

    (indirect: Held by JTR Investments, Limited)
    14,025,761
Footnotes (5)
  • [F1]Restricted stock units (RSUs) pursuant to employment agreement dated 1/1/2015.
  • [F2]Represents the earliest date(s) that any options became exercisable.
  • [F3]Represents the latest date(s) that any vested options expire.
  • [F4]Comprises vested options issued pursuant to various employment agreements and related amendments under the Company's 2004 Stock Option Plan.
  • [F5]Comprises options issuable pursuant to employment agreement dated 1/1/2015.

Documents

1 file
  • 5
    doc5.xmlPrimary

    PRIMARY DOCUMENT